Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Rocaglamide A converts RNA helicase eIF4A into a sequence-specific translational repressor


ABSTRACT: Rocaglamide A (RocA) typifies a novel class of protein synthesis inhibitors that selectively kill aneuploid tumor cells and repress translation of specific mRNAs. RocA targets eukaryotic initiation factor 4A (eIF4A), the prototypical DEAD-box RNA helicase, and its mRNA selectivity is proposed to reflect highly structured 5′ UTRs that are very dependent on eIF4A-mediated unwinding. Here, we show that secondary structure in 5′ UTRs is only a minor determinant for RocA selectivity and RocA does not repress translation by reducing eIF4A activity. Rather, in vitro and in vivo, RocA clamps eIF4A onto a specific sequence motif even after ATP hydrolysis. This artificially clamped eIF4A blocks 43S scanning, leading to premature, upstream translation initiation and reducing gene expression on transcripts bearing the RocA-eIF4A target sequence. In elucidating the mechanism of this lead anti-cancer compound and explaining its mRNA selectivity, we provide the first example of a drug stabilizing sequence-specific RNA-protein interactions. Ribosome profiling, mRNA-Seq, RIP-Seq, and Bind-n-Seq Ribosome profiling for sample 1-5, and 11-15. Sample1 and 2 are replicates of control of DMSO treatment for sample 3-5, and 11, with RocA and PP242 treatments. Sample 12 and 13 are replicates of control of DMSO treatment for sample 14 and 15 with Hipp treatments. mRNA-Seq for sample 6-10. Sample 6 and 7 are replicates of control of DMSO treatment for sample 8-10 with RocA treatments. RIP-Seq for 16-19. Sample 16 and 17 are replicates of control of DMSO treatment for sample 18-19 with RocA treatments. Bind-n-Seq for 20-23. Sample 21 is control of DMSO treatment for sample 22-23 with RocA treatments. Sample 20 is a input contol for protein-bound fraction of sample 21. We stably expressed SBP (streptavidin binding peptide)-tagged eIF4A in HEK 293T-REx cells and purified it via M270 streptavidin beads (life techonologies).

ORGANISM(S): synthetic construct

SUBMITTER: Nicholas Ingolia 

PROVIDER: E-GEOD-70211 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.

Iwasaki Shintaro S   Floor Stephen N SN   Ingolia Nicholas T NT  

Nature 20160615 7608


Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs. RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its messenger RNA selectivity is proposed to reflect highly structured 5' untranslated regions that depend strongly on eIF4A-mediated unwinding. However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actu  ...[more]

Similar Datasets

2016-06-15 | E-GEOD-79392 | biostudies-arrayexpress
2016-06-15 | GSE79392 | GEO
2016-06-15 | GSE70211 | GEO
2018-12-30 | GSE102720 | GEO
2014-07-27 | E-GEOD-56887 | biostudies-arrayexpress
2014-09-13 | E-GEOD-61375 | biostudies-arrayexpress
2015-03-02 | E-GEOD-66411 | biostudies-arrayexpress
2016-05-27 | GSE81966 | GEO
2021-03-03 | GSE120159 | GEO
2024-04-01 | E-MTAB-13945 | biostudies-arrayexpress